CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,391 shares at an average $4.28 ($10,231)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,642 shares at an average $4.28 ($32,701)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 1,761 shares at an average $4.28 ($7,530)
- 4 Open-market sale Chief Financial Officer sold 923 shares at an average $4.27 ($3,945)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 1,772 shares at an average $4.93 ($8,736)
- 4 Open-market sale Chief Financial Officer sold 901 shares at an average $4.93 ($4,438)
- 4 Planned sale Chief Operating Officer sold 1,408 shares at an average $4.94 ($6,962)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,683 shares at an average $4.94 ($37,964)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,404 shares at an average $4.94 ($11,877)
Page 2 of 33 · 660 filings